Trial intelligence / Profile preview

SOLAR: Rosuvastatin vs Atorvastatin and Simvastatin in Hypercholesterolemia

NCT00654173Phase 3Completed

Sponsor
AstraZeneca
Start
Jun 2002
Modality
Orthosteric Ligands
01

Overview

A Phase 3 trial of rosuvastatin in hypercholesterolemia, sponsored by AstraZeneca. Started Jun 2002; status: completed.

02

Drugs

rosuvastatin
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT00654173.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00654173.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call